Search

everythinglearnresearchcommunity

for

Search:↓

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Six existing drugs may help block virus entry in COVID-19.

Immunocompromised patients can develop skin and hair issues due to a virus.

COVID-19 may increase hair loss due to stress and inflammation.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Chikungunya virus often causes skin issues and inflammation.

The study found specific skin and cell changes in patients with monkeypox, helping diagnose and understand the disease.

COVID-19 can increase the risk of hair loss, especially in people over 40.

A severe virus outbreak in yaks on the Qinghai-Tibet Plateau caused high death rates and requires targeted control measures.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Common skin conditions can greatly affect a person's mental health and social life.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

HPV vaccines are generally safe but need further investigation for rare side effects.

HIV patients in Korea often have skin diseases like fungal infections, folliculitis, and seborrheic dermatitis, which are less common with effective HIV treatment.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

Monkeypox skin lesions show full-thickness skin death and swollen skin cells, with the virus found in affected cells.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

A man developed a rare skin condition after a hair transplant surgery.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.